Krawczyk, Janusz <br/><br/>
5-Azacytidine for the treatment of myelodysplastic syndromes.  [electronic resource] 

 -  Expert opinion on pharmacotherapy  Jun 2013 
 - 1255-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7666 
<br/><br/><label>Standard No.: </label>10.1517/14656566.2013.794222  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antimetabolites, Antineoplastic--adverse effects<br/>Azacitidine--adverse effects<br/>Clinical Trials as Topic<br/>DNA Methylation--drug effects<br/>Drug Approval<br/>Humans<br/>Myelodysplastic Syndromes--drug therapy<br/>Prognosis<br/>Quality of Life<br/>Survival